Real-time enrollment status for this histologically confirmed relapsed or refractory b-cell non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 7:56 AM UTC
| NCT Number | NCT07439653 |
| Recruiting Status | Recruiting |
| Condition | Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 155 participants |
| Active Locations | 6 sites in the US |
| Sponsor | TORL Biotherapeutics, LLC |
| Last Updated on CT.gov | August 24, 2026 (4 days ago) |
As of August 28, 2026: Clinical trial NCT07439653 is currently recruiting participants. This phase1 study for histologically confirmed relapsed or refractory b-cell non-hodgkin lymphoma is actively seeking new participants at 6 locations across the United States. The study is sponsored by TORL Biotherapeutics, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07439653 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07439653 was last updated 4 days ago (August 24, 2026). HelloStudys verifies this status automatically.